Patent Assignment
Reel/Frame 076038/0461
Patent Security Agreement
Recorded: 2026-06-25
Pages: 11
Assignor
IDORSIA PHARMACEUTICALS LTD
Executed: 2026-06-25
Assignee
BIOPHARMA CREDIT PLC, AS COLLATERAL AGENT
C/O MUFG CORPORATE GOVERNANCE LIMITED, 51 LIME STREET, 19TH FLOOR, LONDON, EC3M 7DQ, UNITED KINGDOM
Covered Properties
(59)
Alpha-D-Galactopyranoside Derivatives
Application:
19/193,332 →
Publication:
US US20250257056A1
Combination of a CXCR7 Antagonist with an S1P1 Receptor Modulator
Application:
17/773,216 →
Publication:
US US20250228850A1
Medical Use of Daridorexant
Application:
17/996,499 →
Publication:
US US20230134935A1
Macrocycles as Cftr Modulators
Application:
18/550,883 →
Publication:
US US20240208992A1
A Crystalline Form of (4-Methyl-2-[1,2,3]Triazol-2-Yl-Phenyl)-[(R)-3-(3-[1,2,3]Triazol-2-Yl-Benzyl)-Morpholin-4-Yl]-Methanone
Application:
18/263,847 →
Publication:
US US20240116913A1
Crystalline Form of a Piperazinyl-Thiazole Derivative
Application:
18/263,318 →
Publication:
US US20240092772A1
Triazolyl-Methyl Substituted Alpha-D-Galactopyranoside Derivatives
Application:
18/548,833 →
Publication:
US US20240109930A1
CCR6 Receptor Modulators
Application:
18/704,588 →
Publication:
US US20250042881A1
CCR6 Receptor Modulators
Application:
18/705,346 →
Publication:
US US20250011313A1
Clazosentan Disodium Salt, Its Preparation and Pharmaceutical Compositions Comprising the Same
Application:
18/720,031 →
Publication:
US US20250051308A1
Pharmaceutical Combination Comprising an Anti-CD3 Antibody and a CXCR3 Antagonist
Application:
19/109,802 →
Publication:
US US20250381184A1
Crystalline Form of (3S,7S,10R,13R)-13-Benzyl-20-Fluoro-7-Isobutyl-N-(2-(3-Methoxy-1,2,4-Oxadiazol-5-Yl)Ethyl)-6,9-Dimethyl-1,5,8,11-Tetraoxo-10-(2,2,2-Trifluoroethyl)-1,2,3,4,5,6,7,8,9,10,11,12,13,14-Tetradecahydro-[1]Oxa[4,7,10,14]Tetraazacycloheptadecino[16,17-F]Quinoline-3-Carboxamide
Application:
19/111,955 →
Publication:
US US20260098045A1
Combination of Macrocyclic Cftr Modulators with Cftr Correctors and / or Cftr Potentiators
Application:
19/111,782 →
Publication:
US US20250268979A1
Macrocyclic Cftr Modulators
Application:
19/112,147 →
Publication:
US US20260098060A1
Crystalline Adipic Acid Salt Form of a CCR6 Antagonist
Application:
19/136,271 →
Publication:
US US20260272902A1
Vaccine Against Klebsiella Pneumoniae
Application:
19/123,759 →
Publication:
US US20260144856A1
Vaccine Against Klebsiella Pneumoniae
Application:
19/136,851 →
Publication:
US US20260199445A1
Aryl Sulfone and Sulfanone Derivatives as Orexin Receptor Modulators
Application:
19/596,165 →
Macrocyclic Orexin Agonists
Application:
19/599,021 →
2-(1,2,3-Triazol-2-Yl)Benzamide and 3-(1,2,3-Triazol-2-Yl)Picolinamide Derivatives as Orexin Receptor Antagonists
4-(Benzoimidazol-2-yl)-thiazole Compounds and Related Aza Derivatives
Benzimidazole-Proline Derivatives
Benzimidazole-Proline Derivatives
Benzimidazole-Proline Derivatives
1-(Piperazin-1-Yl)-2-([1,2,4]Triazol-1-Yl)-Ethanone Derivatives
Use of Benzimidazole-Proline Derivatives
Crystalline Salt Form of (S)-(2-(6-Chloro-7-Methyl-1H-Benzo[D]Imidazol-2-Yl)-2-Methylpyrrolidin-1-Yl) (5-Methoxy-2-(2H-1,2,3-Triazol-2-Yl)Phenyl)Methanone as Orexin Receptor Antagonist
Crystalline Salt Form of (S)-(2-(6-Chloro-7-Methyl-1H-Benzo[D]Imidazol-2-Yl)-2-Methylpyrrolidin-1-Yl)(5-Methoxy-2-(2H-1,2,3-Triazol-2-Yl)Phenyl)Methanone as Orexin Receptor Antagonist
Crystalline Form of (S)-(2-(6-Chloro-7-Methyl-1H-Benzo[D]Imidazol-2-Yl)-2-Methylpyrrolidin-1 -Yl)(5-Methoxy-2-(2H-1,2,3-Triazol-2-Yl)Phenyl)Methanone and Its Use as Orexin Receptor Antagonists
8-(Piperazin-1-Yl)-1,2,3,4-Tetrahydro-Isoquinoline Derivatives
Pyrazole Compounds and Their Use as T-Type Calcium Channel Blockers
Pyrazole Compounds and Their Use as T-Type Calcium Channel Blockers
(R)-2-Methyl-piperazine Derivatives as CXCR3 Receptor Modulators
Hydroxyalkyl-Piperazine Derivatives as CXCR3 Receptor Modulators
Piperdine CXCR7 Receptor Modulators
Piperidine CXCR7 Receptor Modulators
Preparation of 2-([1,2,3]Triazol-2-Yl)-Benzoic Acid Derivatives
Crystalline Form of N-Butyldeoxygalactonojirimycin
Crystalline Form of N-Butyldeoxygalactonojirimycin
Crystalline Form of N-[1-(5-Cyano-Pyridin-2-Ylmethyl)-1 H-Pyrazol-3-Yl]-2-[4-(1-Trifluo-Romethyl-Cyclopropyl)-Phenyl]-Acetamide
Crystalline Form of N-[1-(5-Cyano-Pyridin-2-Ylmethyl)-1 H-Pyrazol-3-Yl]-2-[4-(1-Trifluo-Romethyl-Cyclopropyl)-Phenyl]-Acetamide
SUBSTITUTED TETRAHYDROPYRAZOLO[3,4-d]PYRIMIDINES AND TETRAHYDROPYRAZOLO[4,3-d]PYRIMIDINES AS C5A RECEPTOR MODULATORS
Crystalline Forms of the CXCR7 Receptor Antagonist (3S,4S)-1-Cyclopropylmethyl-4-{[5-(2,4-Difluoro-Phenyl)-Isoxazole-3-Carbonyl]-Amino}-Piperidine-3-Carboxylic Acid (1-Pyrimidin-2-Yl-Cyclopropyl)-Amide
Alkoxy-Substituted Pyridinyl Derivatives as LPA1 Receptor Antagonists and Their Use in the Treatment of Fibrosis
Pyridin-3-Yl Derivatives
Vaccine Against Klebsiella Pneumoniae
Vaccine Against Klebsiella Pneumoniae
Vaccine Against Klebsiella Pneumoniae
Stable Vaccine Against Clostridium Difficile
(Hetero)Aryl-Methyl-Thio-Beta-D-Galactopyranoside Derivatives
(2-Acetamidyl)Thio-Beta-D-Galactopyranoside Derivatives
2-Hydroxycycloalkane-1-Carbamoyl Derivatives
Alpha-D-Galactopyranoside Derivatives
Combination of an Azetidine LPA1 Receptor Antagonist with Pirfenidone and/or Nintedanib for Use in the Treatment of Fibrotic Diseases
Azetidin-3-Ylmethanol Derivatives as CCR6 Receptor Modulators
Spiro Derivatives of Alpha-D-Galactopyranosides
Galectin-3 Inhibiting 2-Hydroxycycloalkane-1-Carbamoyl Derivatives
A Stable Crystalline Hydrate of Clazosentan Disodium Salt
Hydroxyheterocycloalkane-Carbamoyl Derivatives
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 4, 2014
From: CAROFF, EVA; KELLER, MARCEL; KIMMERLIN, THIERRY; MEYER, EMMANUEL
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 033458/0657 →
Assignment of Assignor's Interest
Aug 7, 2014
From: BOLLI, MARTIN; BOSS, CHRISTOPH; BROTSCHI, CHRISTINE; HEIDMANN, BIBIA
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 033487/0382 →
Assignment of Assignor's Interest
Jan 5, 2015
From: BOSS, CHRISTOPH; BROTSCHI, CHRISTINE; GUDE, MARKUS; HEIDMANN, BIBIA
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 034635/0021 →
Assignment of Assignor's Interest
May 13, 2017
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 042464/0407 →
Corrective Assignment to Correct the Assignee Address Previously Recorded at Reel: 042464 Frame: 0407. Assignor(S) Hereby Confirms the Assignment.
Jun 28, 2017
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 043017/0022 →
Assignment of Assignor's Interest
Nov 22, 2017
From: BOSS, CHRISTOPH; BROTSCHI, CHRISTINE; GUDE, MARKUS; HEIDMANN, BIBIA
To: ACTELION PHARMACEUTICALS LTD
Reel/Frame 044202/0385 →
Assignment of Assignor's Interest
Dec 17, 2020
From: ACTELION PHARMACEUTICALS LTD.
To: IDORSIA PHARMACEUTICALS LTD.
Reel/Frame 054794/0559 →
Assignment of Assignor's Interest
Dec 17, 2020
From: BOSS, CHRISTOPH; BROTSCHI, CHRISTINE; GUDE, MARKUS; HEIDMANN, BIBIA
To: ACTELION PHARMACEUTICALS LTD.
Reel/Frame 054679/0561 →
Assignment of Assignor's Interest
Apr 29, 2022
From: POUZOL, LAETITIA
To: IDORSIA PHARMACEUTICALS LTD.
Reel/Frame 059774/0407 →
Assignment of Assignor's Interest
Jul 18, 2023
From: BRAUNSTEIN, GUY; PAIN, SCOTT; SEBOEK-KINTER, DALMA; VAILLANT, CEDRIC
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 064303/0809 →
Assignment of Assignor's Interest
Jul 28, 2023
From: FOSSHAG, DOMINIK
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 064735/0252 →
Assignment of Assignor's Interest
Aug 1, 2023
From: VON RAUMER, MARKUS
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 064458/0841 →
Assignment of Assignor's Interest
Sep 5, 2023
From: BOLLI, MARTIN; GATFIELD, JOHN; GRISOSTOMI, CORINNA; REMEN, LUBOS
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 064791/0308 →
Assignment of Assignor's Interest
Dec 6, 2023
From: BOLLI, MARTIN; BROTSCHI, CHRISTINE; COMMANDEUR, MALGORZATA; GATFIELD, JOHN
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 065776/0682 →
Assignment of Assignor's Interest
Apr 25, 2024
From: ALLEMANN, OLIVER; CAROFF, EVA; HUBLER, FRANCIS; MEYER, EMMANUEL
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 067223/0159 →
Assignment of Assignor's Interest
Apr 29, 2024
From: ALLEMANN, OLIVER; HUBLER, FRANCIS; MEYER, EMMANUEL
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 067249/0441 →
Assignment of Assignor's Interest
Jun 14, 2024
From: AIGLSTORFER-HAAG, IRIS; ISARNO, THOMAS
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 067729/0911 →
Assignment of Assignor's Interest
Apr 4, 2025
From: ACTELION PHARMACEUTICALS LTD
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 070734/0448 →
Assignment of Assignor's Interest
May 7, 2025
From: BAYER, MONIKA; CHRISTEN, URS; HINTERMANN, EDITH; MARTINIC, MARIANNE
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 071048/0570 →
Assignment of Assignor's Interest
May 16, 2025
From: HERRMANN, CHARLYSE; RAGER, TIMO
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 071140/0893 →
Assignment of Assignor's Interest
May 16, 2025
From: BOLLI, MARTIN; BROTSCHI, CHRISTINE; GATFIELD, JOHN; SIENDT, HERVÉ
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 071301/0848 →
Assignment of Assignor's Interest
May 22, 2025
From: BOLLI, MARTIN; GATFIELD, JOHN; GRISOSTOMI, CORINNA; REMEN, LUBOS
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 071351/0348 →
Assignment of Assignor's Interest
May 29, 2025
From: BOLLI, MARTIN; BROTSCHI, CHRISTINE; GATFIELD, JOHN; HAUWERT, NICOLAAS JOHANNES
To: IDORSIA PHARMACEUTICALS LTD
Reel/Frame 071459/0881 →
Security Interest
May 30, 2025
From: IDORSIA PHARMACEUTICALS LTD
To: IDORSIA LUXEMBOURG SARL
Reel/Frame 071272/0034 →
Security Interest
May 30, 2025
From: IDORSIA PHARMACEUTICALS LTD
To: KROLL TRUSTEE SERVICES LIMITED
Reel/Frame 071272/0108 →